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Abstract	
Protein ubiquitination is a powerful modulator of cellular functions. Classically linked to the 
degradation of proteins, it also plays a role in intracellular localization, DNA damage response, 
vesicle fusion events, and the immune and transcriptional responses. Ubiquitin is versatile and 
can code for several distinct signals, either by adding a single ubiquitin or forming a chain of 
ubiquitins on the target protein. The enzymatic cascade associated with the cellular process 
determines the nature of the modification.  
Numerous efforts have been made for the identification of ubiquitin acceptor sites in the target 
proteins using genetic, biochemical or mass-spectrometry based proteomic methods, such as 
affinity-based enrichment of ubiquitinated proteins, and antibody-based enrichment of 
modified peptides. Modern instrumentation enables quantitative mass-spectrometry strategies 
to identify and characterize hundreds of ubiquitin substrates in a single analysis making it the 
dominant method for ubiquitin site detection. Characterization of the inter-ubiquitin 
connectivity in ubiquitin polymers has also moved into focus, with the field of targeted 
proteomics techniques proving invaluable for identifying and quantifying linkage types found in 
such polyubiquitin chains. 
This review seeks to provide an overview of the many mass-spectrometry based proteomics 
techniques available for exploring this dynamic field. 
 
Word count abstract: 193  
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Introduction	
The	ubiquitin-proteasome	system	
The flow of information, as formulated by Crick 60 years ago, describes how the genetic 
instructions encoded in the DNA is first transcribed into RNA followed by translation into 
proteins[1]. This central dogma of biology is complemented by the final step of protein 
destruction, as formulated by Schoenheimer, erasing the information[2,3]. Protein destruction 
is tightly controlled and important for regulated growth. Failure of this regulation can lead to 
degeneration of cells, ultimately leading to cancer or proteostatic diseases such as Parkinson’s 
and Alzheimer’s [4-8].  
The most important system for selective protein degradation is the ubiquitin-proteasome 
system (UPS). The UPS is the major proteolytic system in eukaryotes, with critical functions in 
cell cycle control, apoptosis, inflammation, transcription, signal transduction, protein quality 
control, and many other biological processes. The system utilizes the small protein ubiquitin as 
a covalent modifier. Proteins selected for destruction are first identified by a cascade of 
enzymes and labeled with ubiquitin. In a second step, the ubiquitin label is recognized by the 
proteasome, a 2-MDa protease complex. The proteasome unfolds the target protein and 
threads the polypeptide chain into the destruction chamber, where three proteolytic subunits 
with different specificities hydrolyze the proteins into smaller peptides. During this process the 
intact ubiquitin molecules are cleaved from target proteins by three proteasome-associated 
deubiquitinases and recycled for further rounds of substrate labeling[9].  
Ubiquitin itself is a small protein (76 amino acids, 8.6 kDa) found in all eukaryotes and highly 
conserved between yeast and human. Eukaryotic genomes usually contain several ubiquitin 
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genes in different genetic locations  (four in humans and yeast). Ubiquitin is expressed as a 
precursor protein, either as a polyubiquitin head-to-tail fusion or as N-terminal fusions with 
ribosomal proteins (Table 1). The gene products are co-translationally processed and mature 
ubiquitin is released by proteolysis [10].  
Mature ubiquitin is transferred to the selected target protein by an enzymatic cascade 
consisting of three enzymes. The first step of the cascade is the activation of ubiquitin by the 
ubiquitin-activating enzyme, E1, a step that requires ATP hydrolysis. The C-terminus of 
ubiquitin forms a thioester with the cysteine side-chain thiol at the active center of the E1 
enzyme. The activated ubiquitin is transferred to a ubiquitin-conjugating enzyme, E2. This 
enzyme, in concert with a ubiquitin ligase, E3, catalyzes the transfer of the activated ubiquitin 
to an ε-amino-group of a lysine side-chain, either in the target protein or on a previously 
conjugated ubiquitin molecule. The specificity of the E2 enzyme can be modulated via 
interaction with different E3 proteins, expanding the conjugation possibilities of the system. 
Finally, ubiquitin-chain formation can be modulated by a ubiquitin chain assembly factor, E4. 
An exception to the E2/E3 pairs are the HECT-domain containing E3 proteins, which accept an 
activated ubiquitin on their own active center and transfer the ubiquitin without the aid of an E2 
to the target protein[11]. Similarly to other post-translational modifications (PTM), ubiquitination 
is reversible. While a cascade of several enzymes is necessary for the transfer of ubiquitin to its 
targets, the removal of ubiquitin is catalyzed by a group of monomeric deubiquitinases (DUBs), 
ubiquitin-specific cysteine proteases (Figure 1) [12]. 
Ubiquitin	signals	
Ubiquitin can code for several distinct signals, by adding just a single ubiquitin or forming a 
chain of ubiquitins on the target protein. An interesting example is the DNA-binding protein 
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PCNA, which can either be mono- or polyubiquitinated depending on the molecular 
function[13]. Mono-ubiquitination was first determined to be essential for receptor 
internalization and intra-cellular transport processes, while the first reported role of the 
ubiquitin chain was its function in proteasomal degradation of substrates[14-16].  
The polyubiquitin chain itself can code several different protein fates depending on the 
properties of the chain. Each of the seven lysine amino groups of ubiquitin as well as the N-
terminus can act as an acceptor site for the extension of the chain, the simplest case being 
formation of homotypic chains utilizing one ubiquitin lysine type for extension. Depending on 
the chain architecture different functions have been associated with polyubiquitination. Chains 
with a lysine 48 (K48) linkage as well as K11-linked chains have been associated with protein 
degradation at the proteasome. K63-linked chains are generally associated with non-
degradative functions, e.g. they can be induced by DNA damage and are associated with a 
stabilization of the attached substrates. Linear chains using a head-to-tail conjugation at the N-
terminus are associated with essential steps in the NF-κB activation[17-21]. Much less is 
known about chains with mixed linkage types or branching points, [22], formed when two 
lysines within a single ubiquitin molecule are used to extend the ubiquitin chain.  
In addition to mono- and polyubiquitination of lysine, the occasional modification of the N-
terminus of proteins or the modification of other amino acids has been reported. In the 
absence of all internal lysine residues the N-terminus of proteins like MyoD can be the 
acceptor site for polyubiquitination[23]. The Coscoy group reported polyubiquitin chains 
covalently linked to cysteine residues in a MHC-I protein, catalyzed by a viral E3 ligase[24]. 
Similarly, recent work showed that polyubiquitin chains linked to a substrates cysteine are 
necessary for cargo translocation across the peroxisomal membranes[25-27] or can be formed 
during the process of chain-assembly for the formation of polyubiquitin chains [28-30]. Other 
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groups reported the occasional modification of threonines and serine hydroxyl groups by 
polyubiquitin chains[29,31]. Ubiquitination on serine, threonine and cysteine has to be analyzed 
with modified proteomic methods because of the chemical nature of the ester linkage, which is 
subject to hydrolysis during the typical workflow of a proteomic experiment.  
Ubiquitin-like	modifiers	
Ubiquitin has a number of close relatives sharing sequence and structural homology. These 
proteins fall into two categories, small proteins that are acting as post-translational modifiers 
like ubiquitin, and those that have a ubiquitin-like domain that is not processed or conjugated. 
The category of the small ubiquitin-like modifiers comprises the SUMO, Nedd8, Urm1, Apg8 
and Apg12 in lower eukaryotes and additionally ISG15, Fat10, Mnsf1 and Ufm1 in higher 
eukaryotes[32]. Each of these modifiers comes with its own conjugation cascade that 
activates, conjugates and removes the respective ubiquitin-like modifier[33]. One major 
difference between modification by ubiquitin and its relatives is, with the exception of SUMO, 
none form polymeric structures on the substrate, with poly-SUMO chains playing a small role 
in overall SUMO signaling. For further details we refer to a number of excellent reviews on this 
subject[33-38].  
For the detection of ubiquitination sites the similarity between the C-terminus of ubiquitin and 
ubiquitin-like molecules is of particular interest. The C-terminus is for all of those modifiers the 
site of conjugation to other proteins. Here the C-terminal glycine is conjugated via its carboxy-
group to the amino group of the lysine side-chain or the N-terminus. Some of the ubiquitin-like 
modifiers share significant homology at the C-terminal site of conjugation (Figure 2) making the 
distinction of the target sites extremely complicated by standard proteomic workflows. 
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The following sections will shed light on recent and current techniques used in unraveling the 
complexity of ubiquitination. 
Identifying	ubiquitination	sites	
Ubiquitination site identification was at the center of numerous biological experiments. Initially 
in order to reveal the precise site of ubiquitination, mutagenesis of the putative target residues 
was performed thus uncovering the site by an exclusion principle. Typically, lysine residues are 
mutated into arginine, as it also has a basic side-chain but is non-nucleophilic and therefore 
cannot be ubiquitinated. This approach assumes no significant biological effect on the cell 
other than abolished ubiquitination is produced by the mutation. However, changing the amino 
acid sequence could have an impact on the structure of the molecule. Some ubiquitination 
reactions have a promiscuous nature and modify any lysine within a certain region, making it 
almost impossible to identify the primary ubiquitination site with genetic methods. Detection 
was usually achieved using western blot techniques employing ubiquitin-specific antibodies, 
with the corresponding limitations in specificity and sensitivity of the antibody and the 
detection reaction. A bottom-up proteomics approach is advantageous as peptides can be 
accurately identified and quantified, and the exact ubiquitination site determined with high 
fidelity. Identification of proteins is unbiased and not limited by the availability of antibodies, 
resulting in the determination of many more substrates. Furthermore, the organism or cell 
culture can be kept under physiological conditions for the experimental approach and subtle 
changes introduced by a specific treatment can be addressed. MS-techniques not only allow 
for a qualitative determination of the site but also enable researchers to quantify differences in 
the levels of ubiquitination among variable conditions. The following sections will deal with 
different proteomic techniques that have been successfully used to identify a plethora of 
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ubiquitination sites in a single experiment or allow the precise quantification of ubiquitin in a 
certain cellular system. 
MS	methods	
Discovery	Proteomics	
In the most common ‘bottom-up’ proteomic workflows[39], the specific proteolytic activity of 
trypsin is utilized, cleaving after lysine and arginine residues to create predictable peptide 
sequences well-suited for LC-MS/MS analysis. The C-terminus of ubiquitin ends in the amino 
acid sequence –RGG, therefore treatment with trypsin leaves a glycine dipeptide as an 
additional stub on the side-chain of modified lysines[40]. Using MS it is possible to identify this 
additional mass shift in the MS/MS spectrum of the peptide. Modified peptides will 
preferentially have higher charge states due to the presence of a mid-sequence amine at the 
end of the diglycine stub, so during the MS measurement the selection of peptides for MS/MS 
can be restricted to higher charge states, excluding doubly-charged species with little loss[41]. 
The homology of the C-terminus of ubiquitin and ubiquitin-like proteins creates an issue of 
ambiguous identifications. The tryptic digest of Nedd8, ISG15 and ubiquitin-modified peptides 
all generate a glycine dipeptide on the lysine acceptor site, making them indistinguishable by 
standard MS based methods (Figure 2).  
Bottom-up MS strategies have been key for identifying new substrates of ubiquitin and the 
specific residues that are modified. The review by Mann and Aebersold offers a comprehensive 
and elegant introduction to the fundamentals of the field[39]. In the ensuing decade, bottom-up 
MS proteomics has fully emerged as one of the most powerful analytical techniques in protein 
science, capable of identifying thousands of proteins and post-translational modifications over 
Probing the ubiquitin landscape 
the course of a few hours. The identification of ubiquitin in samples can be confusing, since 
ubiquitin is annotated in the databases as fusion proteins with ribosomal subunits (Table 1). To 
clarify this, the use of a specialized database containing the sequences of mature ubiquitin and 
mature ribosomal subunits can be helpful. 
Identification of primary ubiquitination sites is the initial goal, often followed up by experiments 
probing how this modification is modulated under certain conditions.  Stable isotope-labeling is 
widely used in quantitative proteomics as a means to compare protein/peptide levels amongst 
two or more samples. Differential isotopic composition creates no physicochemical difference 
between the samples, such as chromatographic elution time or ionization potential, but the 
small mass difference is readily distinguished by the mass spectrometer. Therefore two 
identical peptides arising from different samples can be combined and measured in a single 
run and their relative abundance measured. Introducing the label can be achieved through 
either metabolic or chemical means. A popular metabolic labeling technique called SILAC 
(stable isotope labeling by amino acids in cell culture) involves growing an organism in media 
supplemented with isotopically-coded amino acids, mostly lysine and arginine to conform with 
the trypsin-based bottom-up approach[42].  Exploiting the organism’s own metabolic 
machinery to label proteins minimizes error by reducing sample handling steps. The number of 
isotope combinations that can be multiplexed together is restricted, with three being the 
practical maximum to avoid interference between the isotope distributions. Every different label 
permits parallel comparison to another experimental condition but also adds an additional fold 
of complexity to the sample; mixing an isotopically “light” Lysine (12C614N2)/Arginine (12C614N4) 
proteome with a “heavy” Lysine(13C615N2)/Arginine(13C615N4) proteome effectively doubles the 
number of unique analytes seen by the mass spectrometer, reducing the possibility of 
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observing low-level analytes such as post-translationally modified peptides due to ionization 
suppression effects.  
Chemical labeling strategies are more flexible as they can be applied to any type of sample, 
not just cells grown in culture, and most commonly target the modification of protein or 
peptide primary amine groups. Dimethylation of primary amine groups via reductive 
methylation with formaldehyde offers a cheap and effective labeling strategy. The various 
isotopic combinations allow the parallel comparison of three different conditions[43]. In the 
case of ubiquitin proteomics, fragmentation of a dimethylated GG peptide (methyl groups 
added to the native N-terminus and the distal end of the GG ubiquitin remnant) yields 
characteristic diagnostic ions that can be utilized to help eliminate false positives[44,45]. Both 
SILAC and dimethylation increase sample complexity and compare analyte intensities at the 
MS1 level. A more sophisticated chemical labeling approach uses reagents such as iTRAQ[46] 
and TMT[47], which permit a greater number of channels to be monitored simultaneously. 
Sample complexity is not increased by labeling because of the isobaric nature of the label. This 
means that differential tags have the same mass, such that differentially labeled peptides 
derived from different experiments will all have the same MS1 mass, as opposed to being split 
across multiple signals such as with SILAC or dimethylation, diluting the intensity.  Upon 
MS/MS fragmentation these peptides release unique mass reporter ions; the relative 
abundance of these reporter ions in the MS/MS spectrum is the basis for quantitation between 
samples.  A recent development in labeling called neutron encoding (NeuCode) combines the 
metabolic labeling of SILAC with an ability to multiplex many channels, currently up to 18 when 
used with differential dimethylation[48].It relies on the small mass defects (6 mDa) that can be 
generated between different isotopologues of lysine, creating a nominally isobaric tag that can 
be resolved by a high-resolution FT-MS[48]. 
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Targeted	proteomics	
When the large-scale identification of proteins is not the objective, but rather the robust 
measurement of only a subset of proteins, targeted proteomics techniques are used. Selected 
Reaction Monitoring (SRM) MS is a targeted technique frequently applied to the quantification 
of the different polyubiquitin chain linkages, for example. While traditional shotgun proteomics 
aspires to sequence every peptide present in a trypsin-digested proteome, SRM focuses on a 
pre-selected group of tryptic peptides, detecting them based upon a characteristic conversion 
of the intact peptide into a fragment ion upon high-energy gas-phase collisions within the mass 
spectrometer called a transition (Figure 5a). By comparing this signal with that of a stable-
isotope (13C, 15N, 2H) labeled version of the peptide that was spiked into a cell lysate at a known 
concentration, one can determine the concentration of the peptide in a complex mixture, and 
even calculate the copy numbers of the protein per cell[49,50]. A recently developed technique, 
Parallel Reaction Monitoring (PRM) was adapted to the quadrupole-Orbitrap instruments[51] 
and has also been extended to the quantitative analysis of polyubiquitin chain linkages[52]. The 
Orbitrap mass analyzer allows parallel monitoring of all transitions while the significant increase 
in resolution and mass accuracy over triple quadrupole instruments offers improved selectivity 
in complex matrices.  
Pitfalls	of	ubiquitin	site	identification	
Identifying new ubiquitination sites in a protein poses a challenge on several levels[53]. As with 
other post-translational modifications, the non-modified peptide usually occurs in large excess 
compared to the modified peptide. An enrichment step, either of a specific target or a more 
general enrichment of the modified proteins to reduce the background and boost sensitivity for 
low-level analytes is often required[41,54]. In the case of ubiquitination the large variety of very 
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active, non-specific DUBs amplifies the challenge, requiring addition of a general inhibitor for 
such enzymes to prevent reversal of the target PTM. Since most of the DUBs have a cysteine 
in their active center, treatment with an alkylating chemical agent inactivates these efficiently. A 
number of compounds have been used, but the most common ones are N-ethylmaleimide 
(NEM) and iodoacetamide (IAA). The use of either compound is associated with additional 
challenges for the mass spectrometric analysis. NEM can undergo a hydrolyzation step to 
produce an additional side-product during the alkylation reaction, splitting the signal across 
two peaks in the respective spectra, as well as modifying amino acids other than cysteine[55]. 
The reactivity of NEM towards cysteine residues is much lower than IAA, requiring higher 
concentrations to get a complete inhibition of the DUBs [56]. Off-target alkylation of lysines by 
IAA can lead to a mass-shift indistinguishable from the 114.043 Da mass shift introduced by 
Gly-Gly addition [57]. The modification has different chemical properties and can be resolved 
chromatographically as a peak doublet[57]; it is also not well-recognized by the K-GG peptide 
antibody[58,59]. The detailed analysis of MS/MS spectra of these chemical artifacts shows a 
higher tendency for a   -57 Da or a -144 Da neutral loss, which can be used as an additional 
quality criterion[58]. IAA alkylation of lysine is temperature-dependent with modification only 
occuring at higher incubation temperatures[56], and so can be largely avoided. 
Chloroacetamide has successfully been used as an alternative to these two compounds,[57], 
its’ lower reactivity making it more more specific to cysteine thiol-groups.  However, in terms of 
DUB inhibition to best preserve ubiquitination sites, iodoacetamide is more effective than 
chloroacetamide[56] 
Another challenge is posed by the occurrence of false positive interpretations of the spectra by 
current analytical software like Mascot[60], Sequest[61] or MaxQuant[62]. While the software 
treats ubiquitination as a normal mass shift of one of the amino acids, some of the spectra are 
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annotated as being modified on a C-terminal lysine. This is a very unlikely modification, since 
trypsin cannot cleave adjacent to a modified lysine (Figure 3). These peptides are most likely 
false positives or peptides that carry an asparagine residue (apparent mass shift of 114.043 Da) 
at the C-terminus[63] and should be discarded as false-positive ubiquitination sites.  
Identification	of	sites	in	specific	proteins	
For many biological questions the identification of ubiquitination sites in a specific protein is 
the primary goal. In order to obtain good identification data the main key is sufficient sequence 
coverage of proteolytically-generated peptides. As previously mentioned, it is often necessary 
to enrich for the proteins of interest to overcome the analytical challenge where the PTM 
represents a small fraction of the total population of a low-abundance protein. For many 
targets of the ubiquitin system, several ubiquitination sites can be present in a single substrate. 
These can have different signaling properties, as has been shown for IKKγ[64], or can act 
simply as alternative sites that trigger the same event[65-67].  
Enrichment	by	ubiquitin	pull-down	
Ubiquitin-specific	antibodies	
Antibodies recognizing ubiquitin have been available for a long time[68] and although they were 
able to recognize ubiquitin, cross-reactivity was high. The development of monoclonal 
antibodies recognizing polyubiquitin but not monoubiquitin facilitated the targeted analysis of 
polyubiquitinated material[69]. One of these monoclonal antibodies (FK2) was selected 
because of its high specificity toward polyubiquitinated proteins[70] and was first introduced in 
proteomic studies of the ubiquitinome[71] (Figure 4C). This study identified 670 proteins that 
were enriched under highly denaturing conditions, but lacked the detection of GG-peptides 
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that would boost confidence to make them bona fide identifications. The same strategy was 
later used to characterize the EGF-induced response of the ubiquitin network[72]. A detailed 
comparison of different antibody-based ubiquitinome analyses found that the use of the FK2 
antibody yielded similar results as the use of TUBE-enrichment strategies[73] (see below). 
Using	epitope-tagged	ubiquitin	
With the continuous development and refinement of various molecular biology tools, the study 
of ubiquitination has been pushed forward in the past two decades. The preparation of 
ubiquitin-specific antibodies has been hampered by low affinity and high background, so the 
introduction of N-terminally epitope-tagged ubiquitin as a probe was quickly identified as a 
useful alternative for ubiquitination studies[74]. Tagged ubiquitin allows for a more robust 
purification[75], as it can be performed under strongly denaturing conditions[76]. Cells 
transformed with tagged-ubiquitin formed the basis for several studies in different organisms 
that have been undertaken since, with the first large-scale study performed in yeast[54]. All four 
copies of the ubiquitin gene were replaced by a ubiquitin gene carrying a 6-His tag at the N-
terminus. The His-tag was used to enrich for ubiquitinated material via Ni2+-chelate 
chromatography, that was subsequently digested by trypsin (Figure 4A) and peptides identified 
using MS. In total this led to the identification of 110 proteins with a ubiquitination site. 
Although the purification was done under denaturing conditions, a significant number of 
proteins identified had no diglycine-modified peptide detected (Figure 4). Experiments in yeast 
have shown that the N-terminus of ubiquitin can also be modified by different epitope tags. 
These fusion-proteins can still support growth where all additional copies of wild-type ubiquitin 
have been removed. It is even possible to transfer an N-terminal GST-ubiquitin-fusion, a 26 
kDa epitope tag, to a substrate (MHC Class I Heavy Chain) by the ubiquitin conjugation 
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system[77]. Alternative epitope-tags include myc-, Flag, HA-, His-FLAG and biotin-6His 
double-tag, expressed either ectopically[78-81] or stably integrated [82]. 
In a different approach, a lysine-free ubiquitin mutant was created for the analysis. Here all 
seven lysines of ubiquitin were mutated to arginines, creating a ubiquitin variant that can be 
conjugated to a target but is resistant to digestion by a lysine-specific protease. Following such 
a digest, the intact mutant ubiquitins conjugated to remnant of substrates can be isolated by 
size-selection. This lead to the identification of 1392 ubiquitination sites in human cells[83].  
bio-Ubiquitin	
The interaction of biotin with avidin or streptavidin is one of the strongest non-covalent 
interactions in nature. The bacterial BirA ligase recognizes a specific sequence (avi-tag) and 
covalently adds a biotin moiety[84]. By fusing the avi-tag to the N-terminus of ubiquitin with the 
simultaneous expression of the birA-ligase, ubiquitin can be biotinylated in vivo, facilitating the 
purification of ubiquitinated proteins under stringent wash conditions (Figure 4B). Recently the 
Mayor laboratory constructed a vector allowing expression of a penta-ubiquitin-birA-ligase 
fusion (hexa-ubiqutin in the transgenic mouse). Like wild-type ubiquitin, this version of ubiquitin 
is processed co-translationally, releasing the birA-ubiquitin and the BirA-ligase. The birA-
ubiquitin is then incorporated into the ubiquitin-chains allowing the pull-down of biotin-
ubiqutinated substrates using streptavidin or avidin-beads. Coupled to mass-spectrometric 
analysis, this study identified several hundred ubiquitinated substrates[85-87].  
Ubiquitin	site	identification	using	peptide-specific	antibodies	
Rather than enrichment at the protein level, a peptide-based technique has been developed 
exploiting the characteristic branch structure of ubiquitinated peptides after a tryptic digest. 
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Specific antibodies that recognize lysine residues carrying a glycine dipeptide on the ε-amino 
group have been raised and allow the enrichment for ubiquitinated peptides from complex 
proteomic samples[81,88] (Figure 4E). This technique was used in three landmark papers from 
the Gygi, Mann and Elledge laboratories to identify the largest set, to date, of ubiquitin 
substrates[41,89,90]. Although the identification rate was initially in the range of 300 to 800 
ubiquitination sites[81,88] employment of peptide fractionation, such as isoelectric focusing or 
strong cation exchange chromatography, improved the identification rates to 10000 – 20000 
ubiquitination sites in one study[41,91-93]. Using β-interferon stimulation to stimulate ISG15 
expression as a positive control, Kim et al. estimated the contribution of ISGylation (Figure 2) of 
substrates to the total number of di-glycine modified peptides, and concluded that a negligible 
portion of the total modified peptide population can be attributed to ISG15 modification[89]. In 
the same study, a general DUB was used to cleave all ubiquitin moieties from their substrates 
leaving only the sites modified by Nedd8. Once again the group concluded that the fraction of 
proteins modified by Nedd8 was minor[89]. 
Probing	the	Ubiquitin	chain	topology	
Chain-specific	antibodies	
In 2008 new ubiquitin chain-specific antibodies have been introduced, allowing for the 
detection of specific chain-types in western-blots[94]. Although these have been successfully 
used for the detection of specific ubiquitin chains in western blot analysis, the antibody’s 
performance in large-scale proteomic studies has ben mediocre, although it was used 
successfully for the optimization of the ubiquitin chain quantification by SRM[95]. This is 
probably due to the relatively low affinity of these antibodies and their high background in pull-
down experiments. 
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Ubiquitin	chain	quantifications	
Ubiquitin chain quantification represents a critical complement to primary ubiquitin site 
identifications. Each linkage has a unique structure, with particular linkages associated with 
particular functions. Knowledge of the character of a polyubiquitin chain is essential to 
understanding the purpose of an ubiquitination event on a specific target protein as well as 
exploring how the global linkage landscape is altered by perturbing the system. 
Assessing linkage types can be challenging by traditional molecular biology methods, but 
represents an excellent application of MS-based proteomics. The method takes advantage of 
the generation of unique peptides during the tryptic digest of polyubiquitin chains. Depending 
on the type of chain present in the sample, the diglycine moiety can sit on any of the seven 
lysine residues of ubiquitin. Each of these peptides is proteotypic and can be quantified as a 
proxy for frequency of ubiquitin molecules incorporated into a certain chain type. By using 
heavy-labeled reference peptides it is possible to use absolute quantification for the type and 
number of chains in the samples. 
Depending on the experimental question being addressed, analysis may be applied to whole 
cell lysates to study global effects[6,52,96,97], though protein purification or enrichment is 
necessary to study the linkage types present in an isolated system[21,98]. Care must be taken 
in interpreting the results as the background for an IP can easily number in the hundreds of 
proteins. A drawback of a bottom-up proteomics approach to polyubiquitin is the loss of 
linkage context that occurs during the digestion process, especially in complex biological 
systems. Once reduced to its component parts, it is impossible to know whether signals for 
multiple linkage types arose from a single polyubiquitin chain on a single target or from multiple 
sources. Examples in the literature point to the formation of branched chains (K48, K63 or K48, 
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K11) [22,99]. Unfortunately, the evidence for these branched chain formation is destroyed by a 
complete enzymatic digestion.  
Tandem	Ubiquitin	Binding	Entity	(TUBE)	based	enrichment	
The ubiquitin-associated (UBA) domain is a ubiquitin binding domain that is present in a 
number of different proteins of the ubiquitin pathway[100]. Prominent examples are the 
proteasomal shuttling factors Rad23 and Dsk2, which contain a ubiquitin-like domain and one 
or two UBA-domains [101-103]. Other proteins containing UBA domains are E3 ligases, 
deubiqutinating enzymes and E2s. These domains are well-conserved across evolution and 
consist of a sequence of 40-50 amino acids forming an α-helical structure. Depending on the 
protein, several of theses domains can be arranged in multimers. The specificity of the domain 
can vary with preferences for mono-ubiquitination or towards homotypic chains like K48, K63 
or linear[104-108]. A large study by Raasi and coworkers pinpointed the specificity of 30 of 
these domains[109]. Although the ubiquitin-chain is recognized by Rad23 and transported to 
the proteasome, the chain appears to be protected and disassembly and degradation of the 
substrate is delayed[110]. 
As UBA domains have high affinity for polyubiquitin chains, they have been used as tools for 
enriching polyubiquitinated material[111]. By combining two UBA domains the affinity of the 
probe can be increased, leading to the TUBE probes, also referred as ubiquitin-traps. During 
the purification of the ubiquitin chains the chain itself is protected against rapid disassembly by 
DUBs. By combining several UBA domains in one TUBE the specificity of the chain-enrichment 
can be modulated[112,113]. The technique has been applied to study specific E3 ligase 
substrates in vivo by overexpressing them together with a FLAG-tagged, trypsin-resistant 
TUBE (TR-TUBE)[114]. An interesting alternative for monitoring ubiquitin chains in vivo has 
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been developed by combining the TUBE-probe with fluorescent probes, allowing imaging of 
ubiquitin chains in certain parts of the cell[115]. In their recent study, Yoshida et al. [114] aimed 
to identify substrates of the ubiquitin ligase FBXO21. To achieve this, the E3 was 
overexpressed followed by enrichment using FLAG-tagged TR-TUBES, which - according to 
the authors - protected against deubiquitination. The authors also mentioned that trypsin can 
be hindered in accessing the ubiquitin chains in the presence of the TUBEs, which was 
overcome by completely denaturing the sample. After tryptic digest another level of enrichment 
was achieved by using a-GlyGly-Lys antibodies to pull-out ubiquitinated peptides, which were 
identified by MS. This identified eight ubiquitination sites in substrates of Skp2 and another six 
in substrates of FBXO21[114]. 
Their specificity with respect to ubiquitin binding, however, has been challenged by several 
studies showing that UBA domains interact with UBL domains and other proteins. Some pull-
down experiments using UBA domains found unspecific recovery of ubiquitin chains, likely due 
to interactions of multiple UBAs that overwhelmed the specificity of a single UBA[112,116-118]. 
UbiCRest		
The Ubiquitin Chain Restriction (UbiCRest) assay (Figure 4F) introduced by the Komander 
group provides a means of systematically probing a polyubiquitin chain with a toolbox of DUBs 
of known specificity and using gel-based analysis to determine the linkage varieties present as 
well as the architecture of a heterotypic polyubiquitin chain[119]. Assumptions are made about 
the activity of the DUBs, the specificity of which was largely tested using di-ubiquitin, and 
which may have altered specificities under different concentrations and incubation times or 
may utilize additional binding domains or interaction partners. In addition, the enrichment 
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strategy used to isolate a polyubiquitinated substrate may induce changes in the structure that 
result in resistance to proteolysis by DUBs.  
Post-translational	modifications	on	ubiquitin	
Although ubiquitin is a post-translational modifier it can itself be the target of post-translational 
modifications. Phosphorylation on ubiquitin, at residue S57, was initially reported in the first 
large-scale study in yeast[54]. A number of other large-scale studies extended the list of 
modification to phosphorylations on serines, threonine and tyrosines [120-122], acetylation on 
all internal lysines[123] and the modification of lysine 11 by SUMO[124], another ubiquitin-like 
modification. Serine 65 has been shown to be phosphorylated by the PINK1 kinase[125], and is 
induced after mitochondrial depolarization[126]. The inclusion of phosphorylated ubiquitin into 
the ubiquitin chain alters the structure, generating a different signal[125]. This can change the 
polymerization of the chain as well as the overall amount of ubiquitination in the cell, while the 
overall degradation rates decrease[127]. 
Top-down	based	analysis	
Recent approaches using limited trypsination and so-called middle-down proteomics exploit 
the fact that non-denatured ubiquitin has only a single cleavage site exposed, at R74, 
generating longer stretches of the ubiquitin chain with the branching points preserved 
[128,129].  
While middle-down proteomics approaches have had some success in characterizing 
polyubiquitin chains with respect to their length and architecture[128,129], the field of top-
down proteomics holds significant promise for characterizing the combinatorial modifications 
occurring at the intact protein level, comprised of co-occurring PTMs that combine to generate 
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a particular functional state of a given protein. The top-down methodology skips the protease 
digestion step that reduces whole proteins to peptides and instead seeks to measure what has 
been termed ‘proteoforms’, defined by Kelleher et al. [130] as “the specific molecular form of 
the protein resulting from combinations of genetic variation, alternative splicing, and post-
translational modifications.” PTMs such as phosphorylation and ubiquitination can have a 
significant impact on a protein’s function, and bottom-up proteomics have augmented protein 
databases with the annotation of tens of thousands of modified sites. PTM analysis via top-
down MS gives researchers the opportunity to learn what PTMs are occurring simultaneously 
over the entire length of the polypeptide chain and what the additive/combinatorial effect of 
multiple PTMs occurring in parallel or the temporal relations between them. 
Native MS is an even purer form of top-down analysis, whereby non-denaturing conditions are 
used to isolate the protein analytes, preserving non-covalent protein-protein interactions and 
permitting study of homo- or heteromeric complexes. A tremendous technical benefit of native 
MS is that folded proteins have a lower distribution of charge states, owing to the reduced 
surface exposure of ionizable goups. This boosts the sensitivity for a signal that would be 
otherwise spread across many more channels, such as with ubiquitin where in the native state 
only three charge states exist, compared to eight for the unfolded molecule.  
Outlook	
A full understanding of the ubiquitination status of any particular target protein needs to take 
into account not only the site of modification but also the structure of the attached 
polyubiquitin chain. Several methods might lead to this final goal. For small numbers of 
proteins modern structure determination techniques such as crystallography or NMR might be 
applicable, though the usual problems of gathering enough material of adequate purity will 
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present the usual stumbling blocks. The rapidly developing field of top-down MS might lead 
the charge, which gains momentum as benchtop instrumentation increases in capability 
through ever-climbing resolution and sensitivity, and the enrichment and separation strategies 
become more refined.  
For example, the multiple forms of a protein of several hundred kDa with a conjugated 
tetraubiquitin can be readily resolved, and one might use a toolbox of specific DUBs[119]  to 
probe the connectivity present in a stepwise manner. This represents a true frontier of ubiquitin 
proteomics. With the preservation of the rich, detailed information intrinsic to these polymeric 
structures, we can begin to understand more precisely how a target protein is modified and for 
what downstream purpose.  
Aside from MS, new methods for the analysis of this important post-translational modification 
are appearing on the horizon. The recent report from the Meller laboratory describes the use of 
a nano-pore for the detection of differentially-linked ubiquitin chains[131]. 
With the number of identified ubiquitination sites increasing rapidly, questions about the details 
in signaling can be addressed in depth. Bioinformatic studies are already using the extensive 
data collected in the large scale studies[132,133]. New studies are now starting to combine the 
information of ubiquitination with other post-translational modifications like phosphorylation in 
order to construct more complex networks[134]. New methods for multiplexing samples like 
the NeuCode technique that is based on differences in the nuclear binding energy allow higher 
degrees of multiplexing while not increasing the complexity of the sample[48,135]. This will not 
only allow larger ubiquitination based data sets, but also allows for multiplexing for top-down 
applications as well[136]. 
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Figure	legends	
Figure	1	
The ubiquitin-driven destruction and signaling cycle. Ubiquitin (blue) is processed at the 
ribosome to its mature form. An E1 enzyme binds the mature ubiquitin while hydrolyzing one 
ATP to AMP. The bound ubiquitin is then transferred to an E2 enzyme in cooperation with the 
E3 ubiquitin ligase. The E3 ligase confers specificity, allowing only selected substrates (dark 
grey) to be ubiquitinated. The E2 and E3 combination is selective for both the residue of the 
substrate protein to be modified and, in the case of polyubiquitination, for the linkage type 
formed. The cycle of activation and transfer can be repeated, adding ubiquitin molecules to a 
growing chain on the target protein. If the substrate is modified with more than one ubiqiuitin 
moiety, the linkage type will define the regulatory outcome. K48-linked polyubiquitinated 
substrates are subjected to proteolysis by the proteasome (left panel),  while other 
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polyubiquitin linkage types or mono-/multiple mono-ubiquitination lead to different regulatory 
outcomes. DUBs can edit the ubiquitin topology of the substrate by removing moieties, further 
modulating regulation of the substrate. 
Figure	2	
Alignment of the C-terminus of mature human ubiquitin and other ubiquitin-like modifiers 
(UBLs). For all of these modifiers, conjugation to the substrate protein occurs at the C-
terminus of the UBL. Depending on the sequence of the C-terminus, a tryptic digest leaves 
either a dipeptide or a short oligopeptide on the side-chain, a characteristic used for the 
identification of the modified residue. Trypsin cleaves C-terminal to basic lysine and arginine 
residues (indicated in light green). Ubiquitin, Nedd8 and ISG15 all have an arginine preceding 
the C-terminal glycine-glycine. Tryptic digestion, therefore, generates a glycine-dipeptide on 
the side-chain that is indistinguishable for all three proteins (dark green), while other UBLs 
generate different dipeptides or longer peptides that are more challenging to identify in 
proteomic screens. 
Figure	3	
Chemical structure of a ubiquitinated polypeptide. Trypsin recognizes lysine (light green) 
and arginine (dark green) and cleaves C-terminal to the peptide bond. The first lysine in this 
example polypeptide chain is modified by ubiquitin on the ε-amino-group. A tryptic digest will 
cleave C-terminal to the arginine in the ubiquitin on the side-chain, and it will not cleave after 
the modified lysine residue, due to steric bulk hindering access. 
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Figure	4	
Enrichment strategies for ubiquitinated proteins. A. Expression of an N-terminal poly-
histidine (His) tagged ubiquitin allows enrichment of ubiquitinated proteins using metal-chelate-
affinity. B. Enrichment strategy using the BirA-tag and the co-expression of a specific ligase. 
The N-terminal bio-tag is recognized and in vivo biotinylated by the BirA-ligase. The 
biotinylated ubiquitin is enriched using avidin- or streptavidin-based affinity chromatography. 
C. Ubiquitin-chain specific antibodies recognize a particular polyubiquitin chain and allow the 
enrichment of associated substrate proteins. The specificity can be mediocre, however, and 
their usage is often hampered by high background. D. Tandem Ubiquitin Binding Entities 
(TUBEs) are based on concatenated ubiquitin-associated (UBA) domains. Immobilized TUBEs 
can be used for the chain-specific enrichment of ubiquitinated proteins. E. Diglycine (GG) 
remnant-targeted antibodies are designed to bind tryptic peptides containing the C-terminal 
GG motif of ubiquitin on a modified substrate peptide. These antibodies are used after the 
proteins have been converted into peptides and allow enrichment of ubiquitin-modified 
peptides on a large scale. F. Ubiquitin Chain RESTriction (UbiCRest) was designed to probe 
ubiquitin chains by using a set of DUBs with known specificity. After the enrichment of 
ubiquitinated proteins by other techniques, proteins are probed systematically using chain-
specific DUBs.  
Figure	5	
Targeted proteomics approach using selected reaction monitoring to quantify ubiquitin 
and ubiquitin linkage types. A. Schematic representation of a triple-quadrupole (QQQ) mass 
spectrometer used for SRM analysis. A target precursor ion (e.g. a ubiquitin peptide) is 
selected in the first quadrupole (Q1) of the mass spectrometer and transmitted for 
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fragmentation in the Q2 (collision cell). In the Q3, specific fragment ions are selected, resulting 
in a measureable ion current. This approach is highly specific and allows reproducible 
quantification of a specific set of peptides. Absolute quantification occurs by comparison of 
the ion current trace to a spiked-in heavy-isotope analogue of the same peptide. B. The 
method can be applied to quantify linkage types by selecting precursor ion/fragment ion pairs 
specific to ubiquitin tryptic peptides bracketing one of the 7 lysine residues of ubiquitin. As an 
example, a K48 (left side) and K63 (right side) linked peptides are depicted. The method can be 
applied for all seven linkage types as well as stretches of native ubiquitin to quantify the overall 
abundance of ubiquitin in a sample. 
 
 
Table 1 Ubiquitin genes 
 Human Yeast 
 Gene Gene-symbol Gene Gene-
symbol 
Polyubiquitin Polyubiquitin B UBB Polyubiquitin  Ubi4 
 Polyubiquitin C UBC   
Ribosomal 
fusions 
Ubiquitin-60S ribosomal 
protein L40 
UBA52 40S ribosomal protein 
S31 -  
Rps27 
 Ubiquitin-40S ribosomal Rps27A Ubiquitin-60S Rpl40B 
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protein S27a ribosomal protein L40 
   Ubiquitin-60S 
ribosomal protein L40 
Rpl40A 
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